G P Jarvik

Author PubWeight™ 37.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Research ethics. Research practice and participant preferences: the growing gulf. Science 2011 3.27
2 Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. Am J Hum Genet 1999 2.12
3 Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum Genet 2001 1.85
4 Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25. Am J Hum Genet 1997 1.68
5 Genetic association studies: genes in search of diseases. Neurology 2001 1.65
6 MR imaging of adventitial vasa vasorum in carotid atherosclerosis. Magn Reson Med 2008 1.57
7 Polymorphisms in the human paraoxonase (PON1) promoter. Pharmacogenetics 2001 1.46
8 Analysis of chromosome 1q42.2-43 in 152 families with high risk of prostate cancer. Am J Hum Genet 1999 1.30
9 Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins. Neurology 1998 1.24
10 Anticipation in familial leukemia. Am J Hum Genet 1996 1.23
11 Human PON1, a biomarker of risk of disease and exposure. Chem Biol Interact 2010 1.09
12 A genomic scan of families with prostate cancer identifies multiple regions of interest. Am J Hum Genet 2000 1.05
13 Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele. Arch Neurol 1994 1.03
14 Risk of Alzheimer disease with the epsilon4 allele for apolipoprotein E in a population-based study of men aged 62-73 years. Alzheimer Dis Assoc Disord 1998 0.99
15 Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management. J Pediatr 1993 0.96
16 Autosomal dominant thrombocytopenia: incomplete megakaryocyte differentiation and linkage to human chromosome 10. Blood 2000 0.90
17 Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency. Am J Hum Genet 1999 0.89
18 Genetic linkage analysis of prostate cancer families to Xq27-28. Hum Hered 2001 0.89
19 Segregation and linkage analysis of a quantitative versus a qualitative trait in large pedigrees. Genet Epidemiol 1997 0.89
20 Evidence against linkage of familial combined hyperlipidemia to the apolipoprotein AI-CIII-AIV gene complex. Arterioscler Thromb Vasc Biol 1998 0.87
21 Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype. Pharmacogenetics 2000 0.85
22 Apolipoprotein E genotype and the risk of gallbladder disease in pregnancy. Hepatology 2000 0.85
23 Linkage analysis of 150 high-risk prostate cancer families at 1q24-25. Genet Epidemiol 2000 0.85
24 Alzheimer's disease and the family effect. Nat Genet 1994 0.84
25 Evidence for genetic influences on smoking in adult women twins. Clin Genet 1995 0.84
26 Paraoxonase 1 promoter and coding region polymorphisms in Parkinson's disease. J Neurol Neurosurg Psychiatry 2003 0.83
27 Analysis of quantitative risk factors for a common oligogenic disease. Genet Epidemiol 1995 0.83
28 Clinical characteristics of prostate cancer in an analysis of linkage to four putative susceptibility loci. Clin Cancer Res 2001 0.81
29 The PON1 gene and detoxication. Neurotoxicology 2000 0.80
30 Complex segregation analysis of LDL peak particle diameter. Genet Epidemiol 1993 0.80
31 Germline mutations in the p73 gene do not predispose to familial prostate-brain cancer. Prostate 2001 0.79
32 Impact of family structure on the power of linkage tests using sib-pair methods. Genet Epidemiol 1999 0.79
33 Affective disorders and Alzheimer disease: a missing-link hypothesis. Am J Geriatr Psychiatry 2001 0.78
34 Trisomy 10p: report of an unusual mechanism of formation and critical evaluation of the clinical phenotype. Am J Med Genet 1996 0.75
35 Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management. Curr Probl Pediatr 1994 0.75